Sweden’s Meda Buying U.S. Respiratory Specialist Acton For Aerospan
This article was originally published in The Pink Sheet Daily
Executive Summary
Swedish specialty pharma Meda is buying Acton Pharmaceuticals to get the privately held group’s Aerospan inhaler for treating asthma, approved by FDA in September 2012 and poised – pending satisfaction of further manufacturing requirements – for a U.S. launch in early 2014.